TG Therapeutics (TGTX)
(Delayed Data from NSDQ)
$21.23 USD
-0.85 (-3.85%)
Updated Jul 18, 2024 04:00 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/6/24 |
---|---|
Current Quarter | -0.04 |
EPS Last Quarter | -0.07 |
Last EPS Surprise | -133.33% |
ABR | 1.63 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.01 |
Next Year | 0.63 |
EPS (TTM) | 0.23 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 66.12M | 77.12M | 297.98M | 442.75M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 68.10M | 79.70M | 301.30M | 511.40M |
Low Estimate | 65.05M | 74.90M | 293.30M | 296.01M |
Year ago Sales | 16.07M | 165.82M | 233.66M | 297.98M |
Year over Year Growth Est. | 311.42% | -53.49% | 27.52% | 48.59% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.04 | -0.01 | -0.01 | 0.63 |
# of Estimates | 4 | 4 | 7 | 6 |
Most Recent Consensus | -0.03 | 0.00 | -0.09 | 0.67 |
High Estimate | -0.03 | 0.02 | 0.45 | 1.02 |
Low Estimate | -0.06 | -0.06 | -0.23 | 0.11 |
Year ago EPS | -0.34 | 0.73 | 0.09 | -0.01 |
Year over Year Growth Est. | 88.24% | -101.37% | -111.11% | 6,461.87% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 1 | 0 |
Up Last 60 Days | 0 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.04 | -0.01 | -0.01 | 0.63 |
7 Days Ago | -0.04 | -0.01 | -0.01 | 0.63 |
30 Days Ago | -0.04 | -0.01 | -0.01 | 0.64 |
60 Days Ago | -0.04 | -0.01 | -0.01 | 0.64 |
90 Days Ago | -0.05 | -0.03 | -0.12 | 0.57 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.04 | 0.00 | -0.09 | 0.67 |
Zacks Consensus Estimate | -0.04 | -0.01 | -0.01 | 0.63 |
Earnings ESP | 0.00% | 100.00% | -600.01% | 5.79% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.07 | -0.09 | 0.73 | -0.34 | NA |
Estimate | -0.03 | -0.12 | 0.29 | -0.26 | NA |
Difference | -0.04 | 0.03 | 0.44 | -0.08 | 0.09 |
Surprise | -133.33% | 25.00% | 151.72% | -30.77% | 3.16% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more